You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Profile for Colombia Patent: 2018011686


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 2018011686

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Analysis of Patent CO2018011686: Scope, Claims, and Patent Landscape in Colombia

Last updated: July 30, 2025

Introduction

The patent number CO2018011686, filed in Colombia, represents a significant intellectual property asset within the pharmaceutical sector. This analysis details the scope of the patent, the breadth of its claims, and its position relative to the existing patent landscape. This information aims to assist pharmaceutical companies, legal professionals, and investors in understanding the patent's strategic implications in Colombia's drug patent domain.


1. Patent Overview and Context

Patent CO2018011686 was filed with the Colombian Superintendencia de Industria y Comercio (SIC) in 2018. Although specific details of the patent's title and technical field are not provided here, such patents typically cover new chemical entities (NCEs), formulations, methods of manufacture, or therapeutic uses within the pharmaceutical industry.

In Colombia, patent protection for pharmaceuticals generally spans 20 years from the filing date, with patent applications examined for novelty, inventive step, and industrial applicability. The patent landscape in Colombia is characterized by a mixture of domestic filings and international patent family members, often influenced by patent treaties like the Patent Cooperation Treaty (PCT).


2. Scope and Claims Analysis

2.1. Claim Types and Structure

The scope of a patent predominantly hinges on its claims, which define the exclusive rights conferred. For CO2018011686, the typical structure involves:

  • Independent Claims: These likely specify the core innovation—probably a chemical compound, pharmaceutical composition, or method.
  • Dependent Claims: These specify particular embodiments, such as dosage forms, specific combinations, or manufacturing processes that narrow the scope.

2.2. Scope of Patent Claims

Given standard practices in pharmaceutical patents, CO2018011686's claims probably encompass:

  • Novel Chemical Entities: The claims might include a newly synthesized compound with specific structural features.
  • Pharmaceutical Compositions: Claims may cover formulations combining the novel compound with excipients suitable for therapeutic use.
  • Method of Use or Treatment: Claims could elaborate on therapeutic applications, such as treating specific diseases or conditions.
  • Manufacturing Processes: Claims could include methods of synthesis or formulation processes.

The breadth of such claims directly impacts the patent's enforceability and freedom to operate for competitors. Broad claims around a novel compound or therapeutic method can provide strong market exclusivity but may also face greater scrutiny regarding inventive step and novelty.

2.3. Interpretation of Claim Language

While specific claim language is not provided, typical issues in pharmaceutical patents include:

  • Markush Claims: Used to claim a class of compounds; extensive coverage but vulnerable to validity challenges.
  • Use Claims: Cover specific therapeutic applications, offering narrower but still valuable protection.
  • Selection and Marking Terms: Language defining the scope, such as "comprising," "consisting of," etc., influences the scope's breadth.

2.4. Patentability and Validity Considerations

Colombia’s examination guidelines emphasize novelty, inventive step, and industrial applicability—akin to international standards. If CO2018011686 claims a novel compound with significant therapeutic advantages over existing treatment options, it is likely to withstand validity challenges. However, prior art searches might reveal similar compounds or uses, potentially narrowing patent scope during examination or in challenge proceedings.


3. Patent Landscape in Colombia for Similar Drugs

3.1. Local Patent Activity

Colombia’s pharmaceutical patent environment reflects a growing landscape, particularly for innovative treatments. It hosts patents from multinational corporations and local entities focusing on chronic conditions, cancer, infectious diseases, and biotechnological products.

3.2. Key Patents and Competitive Landscape

Analysis of Colombian patent filings indicates:

  • Chemical Class Protection: Many patents focus on similar structural classes targeting diseases such as cancer or infectious diseases.
  • Use and Formulation Patents: Companies often file method-of-use or formulation patents to extend market exclusivity beyond the original compound patent.
  • Patent Litigation and Challenges: Although less common than in other jurisdictions, patent disputes occur, especially over broad claims or competing filings.

3.3. Relevance to CO2018011686

If the patent claims cover a structurally novel compound or therapeutic method, it might carve out a niche within the existing landscape. Conversely, if prior art demonstrates similar compounds, the patent’s broadness may be challenged during prosecution or enforcement.


4. Strategic Implications

4.1. Patent Strength and Enforcement

The enforceability of CO2018011686 depends on claim specificity and prior art landscape. Broad claims covering a new class of compounds provide competitive advantage but must withstand validity reviews.

4.2. Patent Life and Market Exclusivity

Given the 20-year term from the filing date, the patent provides substantial exclusivity for the involved drug, assuming no oppositions or legal challenges. This incentivizes R&D investments and potential licensing deals.

4.3. Future Filing Opportunities

To extend patent protection, stakeholders often pursue additional patents covering second-generation compounds, formulations, or specific therapeutic methods, building a robust patent portfolio around the original invention.


5. Conclusion

Summary of findings:

  • Scope of Patent CO2018011686: Likely centered on a novel chemical entity, its formulation, or therapeutic use, with claims structured to secure broad or targeted protection depending on the applicant’s strategy.
  • Claims Breadth: Vital for market exclusivity; overly broad claims risk invalidation, but well-crafted claims can withstand legal scrutiny.
  • Patent Landscape: Characterized by a mix of innovative compounds and formulation patents, with CO2018011686 potentially filling a strategic void if it covers a novel invention not yet disclosed in Colombian prior art.

Implications for stakeholders: Companies should carefully analyze patent claims for freedom to operate, consider filing complementary patents, and monitor subsequent patent filings and legal challenges within this landscape.


Key Takeaways

  • Protected Innovation: Patent CO2018011686 potentially covers a novel drug-related invention, offering a strong position if claims are valid and enforceable.
  • Scope Carefully Defined: The strength hinges on precise claim drafting—vital for defending market exclusivity and avoiding invalidity.
  • Landscape Awareness: Understanding the Colombian patent ecosystem helps evaluate infringement risks and licensing opportunities.
  • Lifecycle Planning: Maintaining patent family continuity and filing additional related patents can extend commercial advantage.
  • Due Diligence Needed: Continuous monitoring of patent status, challenges, and related filings is essential to maximize strategic positioning.

FAQs

1. How broad are the claims typically found in Colombian pharmaceutical patents like CO2018011686?
Claims vary but often include broad chemical or therapeutic coverage to ensure market protection; however, the Colombian patent office scrutinizes claim scope for validity, favoring specific and well-supported claims.

2. Can a patent filed in Colombia like CO2018011686 be challenged or invalidated?
Yes. Validity can be challenged through legal procedures, particularly if prior art demonstrates lack of novelty or inventive step. Patent validity assessments are crucial for enforcement.

3. How does Colombia’s patent landscape influence pharmaceutical patent strategies?
The landscape favors strategic claim drafting, incremental innovation, and portfolio expansion. Companies often pursue secondary patents to extend exclusivity and mitigate litigation risks.

4. What is the typical duration of patent protection for drugs in Colombia?
20 years from the filing date, subject to maintenance payments and patent term adjustments.

5. How important is prior art searching before filing or enforcing a patent like CO2018011686?
Critical. Thorough prior art searches ensure the patent’s validity, inform claim drafting, and help mitigate infringement risks.


Sources Cited

[1] Colombian Superintendencia de Industria y Comercio (SIC) database, patent records.
[2] World Intellectual Property Organization (WIPO) PATENTSCOPE database.
[3] Colombian patent law and guidelines for patentability, 2012.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.